Insights into new-onset autoimmune diseases after COVID-19 vaccination

M Guo, X Liu, X Chen, Q Li - Autoimmunity reviews, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review

A Prabhahar, G Naidu, P Chauhan, A Sekar… - Rheumatology …, 2022 - Springer
For the foreseeable future, vaccines are the cornerstone in the global campaign against the
Coronavirus Disease-19 (COVID-19) pandemic. As the number and fatalities due to COVID …

New-onset rheumatic immune-mediated inflammatory diseases following SARS-CoV-2 vaccinations until May 2023: a systematic review

A Nune, V Durkowski, SS Pillay, B Barman, H Elwell… - Vaccines, 2023 - mdpi.com
A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking …

New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome

P Mv, A Auanassova, M Yessirkepov, O Zimba… - Clinical …, 2023 - Springer
The global health crisis caused by the COVID-19 pandemic overwhelmed the capacity of
healthcare systems to cope with the rapidly spreading infection and its associated …

ANCA associated glomerulonephritis following SARS-CoV-2 vaccination: a case series and systematic review

T Thammathiwat, A Banjongjit, K Iampenkhae… - Vaccines, 2023 - mdpi.com
Vaccines against SARS-CoV-2 (COVID-19) proved beneficial for COVID-19 disease
attenuation and preventing virus spreading. Cumulative reports of the rarity of antineutrophil …

Antineutrophil cytoplasmic antibody-associated vasculitis after COVID-19 vaccination with Pfizer-BioNTech

M Suzuki, Y Sekiguchi, M Sasaki, S Inaba… - Internal …, 2022 - jstage.jst.go.jp
The extent of rare side effects of mRNA vaccines for coronavirus disease 2019 (COVID-19)
remains unclear. Several cases of antineutrophil cytoplasmic antibody (ANCA)-associated …

ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review

MAG Campos, TO Valois, LE Magalhães… - Frontiers in …, 2024 - frontiersin.org
With the coverage of COVID-19 vaccination, it has been possible to observe the potential
side effects of SARS-CoV-2 vaccines, with the most common ones being fever, myalgia …

[HTML][HTML] Antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis following COVID-19 vaccination: a case report and literature review

K Uddin, KH Mohamed, AA Agboola, WA Naqvi… - Cureus, 2022 - ncbi.nlm.nih.gov
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an immune-
mediated disorder of small and medium-sized vessels, characterized by the production of …

New insights of antineutrophil cytoplasmic antibody-associated vasculitis from the perspective of COVID-19 vaccination

Y Yang, Y Xiong, G Xu - Clinical and Experimental Immunology, 2023 - academic.oup.com
The occurrence of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV)
has been reported since the coronavirus disease 2019 (COVID-19) vaccination, but whether …

[HTML][HTML] Cardiac tamponade as a complication of microscopic polyangiitis: a case associated with a COVID-19 mRNA vaccine

C Avalos, Y Ahmadzadeh, D Gatsak, SA Moosa… - Cureus, 2023 - ncbi.nlm.nih.gov
Widespread uptake of the coronavirus disease 2019 (COVID-19) vaccinations has become
the world's championed defense against the global pandemic. Four vaccines have been …